SMS Pharmaceuticals enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


4,453	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
45.9	45.9	41.4	36.0	7.4
0.0	0.0	0.0	—	0.0
365	365	311	280	253
4,772	—	—	—	—
319	319	269	244	245
₹509.53	—	—	—	—

1,151	1,151	950	817	713
31.7%	31.7%	32.7%	34.3%	35.4%
0.08×	—	—	—	—

5.32×	—	—	—	—
27.61×	—	—	—	—
35.96×	—	—	—	—
898	887	783	709	522
173	171	139	117	54.5
133	131	105	85.1	22.4
—	59.2	81.7	50.1	22.5
−71.3	−71.3	−41.7	−2.0	−7.5
—	−76.8	−46.4	−7.6	−13.2
—	131	123	52.2	29.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SMSPHARMA₹475.45

SMS Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersINDSWFTLAB SOLARA DCAL UNICHEMLAB GUFICBIO RPGLIFE HIKAL GUJTHEMMcap ₹4,453 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	4,452.7
- Cash, Equiv & ST Investments	7.4	36.0	41.4	45.9	45.9
+ Minority Interest	0.0	—	0.0	0.0	0.0
+ Total Debt	252.5	280.2	310.8	365.0	365.0
Enterprise Value	—	—	—	—	4,771.9
Net Debt (memo)	245.1	244.1	269.4	319.2	319.2
EV per Share	—	—	—	—	509.53

Total Capital	713.0	816.5	950.4	1,150.9	1,150.9
Total Debt/Total Capital	35.41	34.31	32.70	31.72	31.72
Total Debt/EV	—	—	—	—	0.08

EV/Sales	—	—	—	—	5.32
EV/EBITDA	—	—	—	—	27.61
EV/EBIT	—	—	—	—	35.96
Reference Items — Trailing FY Values
Sales	522.1	709.3	782.7	886.9	897.8
EBITDA	54.5	116.6	139.0	171.3	172.9
EBIT	22.4	85.1	104.7	131.4	132.7
Operating Cash Flow	22.5	50.1	81.7	59.2	—
Free Cash Flow	-7.5	-2.0	-41.7	-71.3	-71.3
FCFF (free cash flow to the firm)	-13.2	-7.6	-46.4	-76.8	—
Capital Expenditure	29.9	52.2	123.4	130.6	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.